Derniers ajouts - Age-Related Macular Degeneration - Dry
|
Reticular pseudodrusenvu 104 fois23 Février 2025
|
|
Reticular pseudodrusenvu 110 fois23 Février 2025
|
|
Reticular pseudodrusenvu 106 fois23 Février 2025
|
|
Reticular pseudodrusenvu 95 fois23 Février 2025
|
|
Reticular pseudodrusenvu 97 fois23 Février 2025
|
|
Reticular pseudodrusenvu 90 fois23 Février 2025
|
|
Reticular pseudodrusenvu 109 fois23 Février 2025
|
|
Reticular pseudodrusenvu 107 fois23 Février 2025
|
|
Reticular pseudodrusenvu 99 fois23 Février 2025
|
|
Reticular pseudodrusenvu 107 fois23 Février 2025
|
|
Reticular pseudodrusenvu 93 fois23 Février 2025
|
|
Reticular pseudodrusenvu 100 fois23 Février 2025
|
|
Reticular pseudodrusenvu 96 fois23 Février 2025
|
|
Reticular pseudodrusenvu 100 fois23 Février 2025
|
|
Reticular pseudodrusenvu 101 fois23 Février 2025
|
|
Reticular pseudodrusenvu 112 fois23 Février 2025
|
|
Reticular pseudodrusenvu 105 fois23 Février 2025
|
|
Reticular pseudodrusenvu 95 fois23 Février 2025
|
|
Reticular pseudodrusenvu 95 fois23 Février 2025
|
|
Reticular pseudodrusenvu 87 fois23 Février 2025
|
|
Reticular pseudodrusenvu 91 fois23 Février 2025
|
|
54 year old female with a lot of drusenvu 91 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 86 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 89 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 84 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 103 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 100 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 94 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 93 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 143 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 143 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 133 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 127 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 144 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 144 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 138 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 128 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 138 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 122 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 113 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 104 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 103 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 112 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 132 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 130 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 114 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 130 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Optic Disc Melanocytoma - Atypicalvu 250 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 222 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 221 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 225 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 220 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 231 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 229 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 224 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 243 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 231 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 256 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 236 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 224 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 225 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 233 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 221 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 222 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 208 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 234 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 206 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 196 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Soft Drusenvu 247 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 266 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 247 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 241 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 242 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 278 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 258 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 234 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 247 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 249 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 257 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 251 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 276 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 258 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 250 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 290 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 271 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 237 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 263 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 251 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 225 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 252 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 244 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 267 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 267 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 270 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 221 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 240 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 265 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 265 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 259 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 286 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
| 582 photos sur 6 page(s) |
1 |
 |
|
|
|
